📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Reply to: "Reply to: 'Response to DAA therapy in the NHS England Early Access Programme for rare HCV subtypes from low and middle income countries'". (2018)

First Author: Da Silva Filipe A

Attributed to: Nottingham Molecular Pathology Node (NMPN) for Integrated Multi-platform Biomarker Research and Knowledge Transfer funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jhep.2017.11.044

PubMed Identifier: 29339112

Publication URI: http://europepmc.org/abstract/MED/29339112

Type: Journal Article/Review

Volume: 68

Parent Publication: Journal of hepatology

Issue: 4

ISSN: 0168-8278